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AbSTR ACT
Cassipourea congoensis (syn. Cassipourea malosana) is used in 
African countries as a skin-lightening agent. Two previously 
unreported cycloartane triterpenoids, 26-hydroxy-3-keto-24-
methy lenecycloartan-30-oic acid 1 and 24-methyle ne-
cycloartan-3β,26,30-triol 2 along with the known mahuannin 
B 3, 7-methoxymahuannin B 4, 7-methoxygeranin A 5, methyl-
3-(4-hydroxy-3-methoxyphenyl)-2E-propenoate, glycerol-
1-alkanoate, (E)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enal 
6, (-)-syringaresinol 7, and stigmast-5-en-3-O-β-D-glucoside, 
were isolated from the roots of C. congoensis. The crude extract 
and compounds 1 and 5 were found to inhibit the production 
of melanin at 10 µM with low cytotoxicity validating the ethno-
medicinal use of this plant.
Introduction
Several topical agents are available to treat hyperpigmentation and 
act at different levels of the melanogenesis pathway [1, 2]. The 
most commonly used compounds are p-hydroquinone, corticos-
teroids, and mercurials [3]. The long-term use of these products 
may cause undesirable cutaneous or systemic side effects [3–5]. 
p-Hydroquinone was one of the earliest treatments for hyperpig-
mentation and remains the standard against which other treat-
ments are measured [2, 6]. The misuse of this compound as a skin-
lightening agent, despite its sale being prohibited in many coun-
tries, is significant, although its use is associated with serious side 
effects, including irritant contact dermatitis and exogenous ochro-
nosis [3, 5, 7]. We have previously reported the nontoxic melanin 
production inhibitors from the South African medicinal plant, Gar-
cinia livingstonei  T.Anderson (Clusiaceae), which is used ethnome-
dicinally for skin-lightening purposes [8] and we now report the inves-
tigation of a second species used for its skin-lightening properties, 
Cassipourea congoensis R Br. ex DC (Rhizophoraceae). p-Hydroqui-
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none inhibits tyrosinase, preventing the conversion of tyrosine to 
dihydroxyphenylalanine, a precursor to melanin. Thus, tyrosinase 
is a target in the search for a medically acceptable, natural, skin-
lightening agent for medical or cosmetic purposes.
C. congoensis is a plant endemic to Africa, growing as a shrub but 
sometimes a small tree of 3–5 m high on forest river banks. It is dis-
tributed across Senegal to Nigeria and easterly across the Congo 
basin to Uganda, Tanzania, and Malawi [9]. C. congoensis was previ-
ously named Cassipourea africana Benth. or Weihea africana (Benth.) 
Oliv. [10]. The fruits of C. congoensis are used in Nigeria as a substi-
tute for tamarind (Tamarindus indica) L. (Fabaceae) in preparing local 
pap, a maize meal, and its nutritional content has been studied [11]. 
It is also regarded as a synonym of Cassipourea malosana (Baker) 
Alston (Rhizophoraceae) that is restricted to eastern Democratic Re-
public of Congo, Ethiopia, and south to South Africa. C. malosana is 
also reported to be closely related to, and often confused with, Cas-
sipourea flanaganii Schinz (Alston) (Rhizophoraceae) and C. flanaganii 
is, used traditionally in South Africa as a skin-lightening agent [12]. 
The Cassipourea genus is reported to yield sulfur-containing com-
pounds that include gerrardine [13], guinesine B, and guinesine C 
[14], sulfur-containing amides that include cassipoureamide A and 
B [15], euphane and lupane type triterpenoids [16, 17], flavonols, 
flavonol glycoside and biflavonoids [18–20] and bioactive monocy-
clic diterpenoids [16] . Extractives from the stem bark of C. malosana, 
including 2 novel flavan dimers, were tested against human ovarian 
cancer cells and showed very little activity [21].
Two previously unreported cycloartane triterpenoids, 26-hy-
droxy-3-keto-24-methylenecycloartan-30-oic acid 1  and 
24-methylenecycloartan-3β,26,30-triol 2 along with the known ma-
huannin B 3, 7-methoxymahuannin B 4, 7-methoxygeranin A 5, me-
thyl-3-(4-hydroxy-3-methoxyphenyl)-2E-propenoate, glycerol-1-al-
kanoate, (E)-3-(4-hydroxy-3-methoxyphenyl) prop-2-enal 6, (-)-sy-
ringaresinol 7, and stigmast-5-en-3-O-β-D-glucoside, were isolated 
from the roots of C. congoensis. The compounds 1–7, together with 
the crude extract, were screened for cytotoxicity against melano-
cytes (human primary epidermal melanocytes, ATCC) as well as for 
tyrosinase and melanin inhibitory activity. The crude extract and 
compounds 1 and 5 were subsequently found to inhibit the pro-
duction of melanin at both 10 and 100 µM with low cytotoxicity 
validating the ethnomedicinal use of this plant. No previous stud-
ies have assessed the cytotoxicity, the effect on inhibition of tyrosi-
nase, or melanin inhibitory activity of C. congoensis.
Results and Discussion
In the present study we report the isolation of 2 new cycloartane 
tritepernoids, 26 hydroxy-3-keto-24-methylenecycloartan-30-oic, 
acid 1 and 24-methylenecycloartan-3β,26,30-triol 2 together with 
the known proanthocyanidins, mahuannin B 3 [19], 7-methoxy-
mahuannin B 4 [19], 7-methoxygeranin A 5[20], methyl-3-(4-hy-
droxy-3-methoxyphenyl)-2E-propenoate, glycerol-1-alkanoate, 
(E)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enal 6, (-)-syringares-
inol 7, and stigmast-5-en-3-O-β-D- glucoside and screening for ty-
rosinase inhibitory activity and the subsequent inhibition of mela-
nin formation. These compounds were isolated from the roots of 
C. congoensis. Both the roots and the bark of the plant are used as 
skin-lightening preparations.
Compound 1 was isolated as a white amorphous powder and 
the ESI( + )-HRMS indicated a molecular formula of C31H48O4 and 8 
degrees of unsaturation. The IR spectrum indicated the presence 
of a ketone group, a carboxylic acid and double bonds, shown by 
absorption bands at 3438, 1730, 1707, and 1621 cm − 1. The 1H 
and13C NMR resonances for compound 1 were in close agreement 
with those of the reported 3-oxo-24-methylene cycloartan-26-ol 
[22, 23]. The 13C NMR spectrum indicated the presence of a ketone 
(δC 216.9) and a carboxylic acid group carbon resonance (δC 181.1). 
The 1H NMR spectrum showed a shielded pair of doublets (δH 0.87, 
d, J = 4.4 Hz; 0.50, d, J = 4.4 Hz) characteristic of the 2 H-19 cyclo-
propane ring protons. The corresponding C-19 resonance (δC 29.8) 
showed correlations in the HMBC spectrum with the H-8 (δH 1.83, 
m) and H-5 (δH 1.70) resonances. The H-5 resonance showed cor-
relations with the C-3 keto group carbon resonance and the corre-
sponding C-5 resonance with the 3H-28 (δH 1.09, s) and 3H-29 (δH 
1.02, s) methyl group proton resonances. The H-8 resonance 
showed a correlation with the carboxylic acid group carbon reso-
nance, and hence this group was placed at C-30. The H-8 resonance 
also showed a correlation with the C-13 resonance (δC 47.9), which, 
in turn, showed correlations with the 3H-18 (δH 1.05) and H-20 (δH 
1.48) resonances. The H-20 resonance showed coupling in the 
COSY spectrum with the 3H-21 doublet resonance (δH 0.92, d, 
J = 6.3 Hz).
The 13C NMR spectrum showed a hydroxymethylene carbon res-
onance (δC 66.1), which was assigned as C-26, with corresponding 
nonequivalent oxymethylene protons seen as a pair of double dou-
blets (δH 3.56, dd, J = 7.0, 10.4 Hz; 3.51, dd, J = 10.4, 7.0 Hz). The 
H-26 resonances were seen to be coupled in the COSY spectrum 
with each other and the H-25 resonance (δH 2.36, sextet, J = 7.0 Hz) 
and this resonance was seen to be coupled to the 3H-27 doublet (δH 
1.04, d, J = 7.0 Hz) and long range coupled to a pair of vinyl methyl-
ene protons (δH 4.88, s; 4.82, s) assigned as the 2 H-31 protons. The 
HMBC spectrum showed correlations between the corresponding 
C-31 resonance (δC 109.9) and the H-25 resonance and between 
the C-24 resonance (δC 152.0) and the 2 H-26, 3H-27 and 2 H-22 
resonances. Based on the above spectral data, compound 1 was 
identified as 26-hydroxy-3-oxo-24-methylene cycloartan-30-oic 
acid. This compound has not been reported previously.
The IR spectrum of compound 2 showed the presence of a hy-
droxy group and double bond with absorption bands at 3432 and 
1623 cm − 1, respectively. The 1H and 13C NMR resonances for com-
pound 2 differed slightly from those of compound 1 as the ketone 
and carboxylic acid carbon resonances observed in the 13C NMR 
spectrum of 1 were absent in 2 but 2 new oxygenated carbon reso-
nances were present at δC 78.9 (CH) and δC 64.8 (CH2). Correlations 
were observed in the HMBC spectrum between the 3H-28 (δH 0.81, 
s), the 3H-29 (δH 0.97, s), and H-5 (δH 1.33) resonances and the res-
onance at δC 78.9, indicating the presence of a hydroxy group at 
C-3. The hydroxy group at C-3 was assigned as β due to the chemi-
cal shift of δC 78.9, typical for a 3β-substituted hydroxy group as 
opposed to δC 76.8 when the 3-hydroxy group is in the α-position 
[22]. This assignment was confirmed by correlations seen in the 
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NOESY spectrum between the H-3/H-5 and H-3/3H-28 resonances. 
Instead of the C-30 methyl group being oxidized to a carboxylic acid 
as in 1, it was oxidized to an oxymethylene (δC 68.2) group in 2. The 
C-30 resonance showed a correlation in the HMBC spectrum with 
the H-8 resonance (δH 1.56, m). The side chain remained the same 
as for compound 1. This compound was found to be the previously 
unreported 24-methylenecycloartan-3β,26,30-triol.
C. congoensis is closely related to and is often confused with 
C. flanaganii, a plant used in South Africa as a skin-lightening agent 
[12]. The widespread use of this plant and its related species for 
skin-lightening purposes make the investigation into both its effi-
cacy and safety of importance. Tyrosinase is a key enzyme in the 
production of melanin as it catalyzes the rate-limiting step in the 
production of this pigment. The inhibition of tyrosinase by the test 
compounds would indicate that tyrosinase inhibition may be one 
of the mechanisms by which these compounds operate and it would 
give a good indication of which compounds are responsible for the 
skin-lightening effect of the plant extract. All compounds tested as 
well as the crude extract showed significant inhibition of tyrosinase 
(p < 0.01) when compared to the negative controls (PBS and DMSO). 
However, the effect of the crude extract was greater than that of 
any of the individual compounds tested. Furthermore, unlike the 
isolated compounds, the inhibitory effect of the crude extracts on 
tyrosinase exceeded that of the positive control, p-hydroquinone, 
which is also used as a skin-lightening agent, (▶Fig. 1).  Further 
characterization showed that the crude extract and a selection of 
its isolated compounds (compounds 1 and 5, selected based on 
their very differing levels of potency on tyrosinase activity) are sig-
nificantly (p < 0.001) inhibiting the production of melanin in the 
human primary epidermal melanocytes, compared to the negative 
controls, over both 24 and 48 h at the concentrations used (▶Fig. 2). 
Their effect, however, did not appear to be time-dependent. There 
was no significant increase in melanin production in either the 
crude extract or isolated compounds when compared to p-hydro-
quinone (p  ≤  0.1), thus demonstrating the inhibitory potential of 
both the crude extract and the compounds. Interestingly, the ex-
tent of inhibition of melanin synthesis did not mirror that of tyrosi-
nase activity for the crude extract and compounds 1 and 5. For the 
latter compound, the inhibition of melanin was far greater than ex-
pected based on its effect on tyrosinase activity which was relative-
ly low compared to that of the crude extract and compound 1. This 
result may suggest that the crude extract’s, and some of its isolat-
ed compounds’, mechanism of action may also involve their inhi-
bition of other enzymes involved in melanin synthesis such as ty-
rosinase related proteins 1 and 2 (TYP-1 and TRP-2) [24]. To shed 
further light on how these compounds behave in relation to mela-
nin synthesis their effect on the activities of tyrosinase, TRP-1 and 
TRP-2 in melanocytes needs to be investigated.
Cytotoxicity towards melanocytes was determined using a neu-
tral red assay (▶Fig. 3a–c) over 3 independent experiments (n = 3). 
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▶Fig. 1 The effect of compounds 1–7 and HQ (p-hydroquinone) at 
10 and 100 µM and crude extract at 1 and 10 mg/mL of C. congoensis 
on tyrosinase activity.  * p < 0.001 compared to the negative controls. 
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▶Fig. 2 The effect of compounds 1 and 5 at 10 and 100 µM and 
crude extract at 1 and 10 mg/mL of C. congoensis for 24 h (top) and 
48 h (bottom) on melanin content in primary melano-
cytes.  * p < 0.001 compared to the negative controls. Each data point 
represents n = 3 and is representative of 3 independent experiments. 
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No significant cytotoxicity was detected for the test compounds or 
crude extract relative to the negative controls at a confidence limit 
of 95 % (media, and vehicle control, p < 0.05). The crude extract did 
show a greater cytotoxicity than the individual compounds isolated.
The results of this study show that the crude extract (as used for 
skin-lightening purposes) as well as the isolates studied had no sig-
nificant cytotoxicity when compared to the negative controls while 
still showing significant inhibition of tyrosinase and, in the case of 
the crude extracts and compounds 1 and 5, melanin production by 
primary melanocytes. Overall, this result suggests this plant, and 
its compounds, may be a good alternative to preparations contain-
ing p-hydroquinone.
Spectra for compounds 1 and 2 are available as Supporting In-
formation.
Materials and Methods
General experimental procedures
Optical rotations were measured on a JASCO P-1020 polarimeter. 
ECD spectra were obtained on an Applied Photophysics Chirascan 
CD spectrometer using a 1-mm cell and acetonitrile as the solvent. 
FTIR spectra were recorded using a Perkin-Elmer (2000) spectrom-
eter. 1D and 2D NMR spectra were recorded in CDCl3 on a 500 MHz 
Bruker AVANCE NMR instrument at room temperature. Chemical 
shifts (δ) are expressed in ppm and were referenced against the 
solvent resonances at 7.26 and 77.23 ppm for 1H and 13C NMR spec-
tra, respectively. ESI( + )-HRMS mass spectra were recorded on a 
Bruker MicroToF mass spectrometer using an Agilent 1100 HPLC to 
introduce samples (University of Oxford). Column chromatogra-
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▶Fig. 3 Percentage viability of human primary epidermal melanocytes exposed to crude extracts of 1 and 10 mg/mL and compounds 1 µM a, 
10 µM b, and 100 µM c from C. congoenesis for 24 and 48 h. No significant cytotoxicity was observed when compared to the negative controls 
(p < 0.05). Each data point represents n = 3 and is representative of 3 independent experiments.
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phy was done using SiO2 packed to 4- or 1-cm diameter gravity col-
umns. TLC was done on aluminum-backed precoated SiO2 plates 
(Merck 9385) visualized using anisaldehyde spray reagent.
Plant material
The roots of C. congoensis were collected by Mr. Nana Victor in No-
vember 2010 at Mbalmayo, southern Cameroon. A voucher speci-
men (1773SRF/CAM) was deposited at the National Herbarium, 
Yaoundé, Cameroon.
Extraction and isolation of compounds from  
C. congoensis
The powdered root of C. congoensis (1.3 kg) was extracted succes-
sively with refluxing CH2Cl2 and MeOH for 48 h each. The solvents 
were evaporated under reduced pressure using a rotary evapora-
tor (Büchi type R-205) to give brownish extracts of 16.2 g and 47.2 g 
of extract respectively. The CH2Cl2 extract was separated using col-
umn chromatography over silica gel (Merck 9385) eluting with 
n-hexane with increasing amounts of CH2Cl2. Once 100 % CH2Cl2 
had been reached, a step gradient elution using methanol was used 
to yield several fractions (75 mL each). Combined fractions 32–39 
were purified using a n-hexane-CH2Cl2(1:1) system to give 26-hy-
droxy-3-oxo-24-methylene cycloartan-30-oic acid 1 (10.5 mg). Pu-
rification of combined fractions 66–69 using a n-hexane-CH2Cl2 
system (1:1) gave 24-methylenecycloartan-3β,26,30-triol 2 
(12.5 mg) whereas purification of combined fractions 105–110 
using 100 % CH2Cl2 gave mahuannin B 3 (10.3 mg), 7-methoxyma-
huannin 4 (17.5 mg), and glycerol 1-alkanoate. The MeOH extract 
(47.2 g) was separated using column chromatography over silica 
gel using CH2Cl2-EtOAc mixtures of increasing polarity to yield sev-
eral fractions (75 mL each) that were combined following analyti-
cal TLC analysis. Fractions 47–59, 126–131, and 139–154 were pu-
rified using CH2Cl2-EtOAc (3:1), CH2Cl2-EtOAc (1:5), and EtOAc 
100 % to give 7-methoxygeranin A 5 (12.8 mg), (E)-3-(4-hydroxy-
3-methoxyphenyl)prop-2-enal, 6 (15.2 mg), and (-)-syringaresinol 
7 (18.2 mg), respectively. Stigmast-5-en-3-O-β-D-glucoside 
(25.6 mg) was obtained from combined fractions 139–154 along-
side 1. Structures are shown in ▶Fig. 4.
26-Hydroxy-3-oxo-24-methylenecycloartan-30-oic acid (1):
White amorphous powder; (10.5 mg,  > 98 % pure; from NMR) 
[α]25D + 19 (c 0.0270, CHCl3); IR (neat) νmax 3438, 2957, 2853, 1707, 
1621 cm − 1; ESI( + )-HRMS m/z 507.3447 [M + Na] + (calcd for 
C31H48O4Na, 507.3450); see ▶Table 1 for 1H NMR (500 MHz, CDCl3) 
and 13C NMR (125 MHz, CDCl3) data.
24-Methylenecycloartan-3β,26,30-triol (2)
White amorphous powder; (12.5 mg,  > 90 % pure; from NMR) 
[α]25D + 19.5 (c 0.0350, CHCl3); IR (neat) νmax 3432, 2957, 2853, 
1623 cm − 1; ESI( + )-HRMS m/z 495.3793 [M + Na] + (calcd for 
C31H52O3Na, 495.3814); see ▶Table 1 for 1H NMR (500 MHz, CDCl3 
and 13C NMR (125 MHz, CDCl3) data.
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Pharmacological assays
Cell culture
Human primary epidermal melanocytes (ATCC) were cultured in 
Dermal Cell Basal Media (ATCC) supplemented with Adult Melano-
cyte Growth Kit Components and 2 % penicillin-streptomycin-am-
phorectin B Solution (ATCC) and were grown as per manufacturer’s 
instructions. On reaching 90 % confluency, cells were passaged once 
prior to plating for cell culture experimentation. Positive controls, 
p-hydroquinone (purity  > 99 %) and hydrogen peroxide (30 wt % in 
water) used were purchased from Sigma-Aldrich.
Effect of C. congoensis crude extract and compounds on 
the viability of human primary epidermal melanocytes
Compounds were resuspended from a stock solution (DMSO,  > 99.7 %, 
Sigma-Aldrich) in 16 nM K3PO4 buffer (both from Sigma-Aldrich) 
at concentrations of 1, 10, and 100 μM. The crude extract was tested 
at concentrations of 1 mg/mL and 10 mg/mL. Human primary epi-
dermal melanocytes were plated in 96-well plates at a concentra-
tion of 1 × 105 cells/well. Following a 24-h incubation, cells were 
treated with respective concentrations of compound and crude ex-
tracts (as above), as well as DMSO (the final concentration of 
DMSO  ±  cells was 0.1 %), hydrogen peroxide (30 wt % in water), 
which was used as the positive control and media alone and further 
incubated for 24 h and 48 h to determine the extent of any toxicity 
over time. Neutral red (Sigma-Aldrich) was dissolved in water at a 
concentration of 3.3 µg/mL. Cell culture media with compound or 
crude extract was removed from cells and 20 µL neutral red solu-
tion was added to cells. Following a 2-h incubation at 37 °C, the 
neutral red solution was removed and cells rinsed with DPBS. Two 
hundred microliters of a solution containing 1 % acetic acid in 50 % 
EtOH/deionized H2O was added to solubilize the dye. Following a 
20-min incubation, supernatants were read using a Tecan Infinate 
Pro 200 plate reader at 540 nm and the cell viability determined.
Effect of C. congoensis crude extract and compounds on 
tyrosinase activity
The tyrosinase assay used is one previously described by Chou 
et al. [25]. Two hundred ten microliters of L-Dopa ( > 98 %, Sigma-
Aldrich) was dissolved in 16 ηM K3PO4 buffer and incubated at 25 °C 
for 10 min with 7.5 μL of crude extract (1 and 10 mg/mL) each com-
pound (10 and 100 μM), DMSO 0.1 %, 16 ηM K3PO4 buffer (the neg-
ative control and blank, respectively) or p-hydroquinone ( > 99 %, 
Sigma-Aldrich) (10 or 100 μM) (the positive control as p-hydroqui-
none is a known inhibitor of tyrosinase) [26], plus 7.5 μL of tyrosi-
nase (mushroom, lyophilized powder,  ≥ 1000 unit/mg solid, Sig-
ma-Aldrich) (or 20 mM K3PO4 buffer as a blank). The absorbance 
was determined at 475 nm using a Tecan Infinate Pro 200 plate 
reader.
Percentage inhibition of tyrosinase activity was determined 
using the following equation
((1−B/A)  ×  100) 
where A = change in optical density at 475 nm (OD475)/min without 
sample (negative controls) and B = change in OD475/min with 
sample.
▶Table 1 1H and 13C NMR data for compounds 1 and 2 (CDCl3, 500 MHz 
for 1H NMR and 125 MHz for 13C NMR spectra).
Compound 1 Compound 2
No δC δH (J in Hz) δC δH (J in Hz)
1α 33.5 1.87 m 32.3 1.60 m
β 1.61 m 1.26 m
2α 37.5 2.72 dt (6.2, 15.0) 30.4 1.77 m
β 2.31 dt (4.4, 15.0) 1.58 m
3 216.9 – 78.9 3.28 dd  
(4.3, 11.1) 
4 50.1 – 40.7 –
5 47.8 1.70 m 47.5 1.33 m
6α 21.0 1.49 m 21.6 1.63 m
β 1.01 m 0.80 m
7α 28.4 2.23 m 27.5 1.93 m
β 1.35 m 1.46 m
8 45.4 1.83 m 48.9 1.56 m
9 20.5 – 19.8 –
10 27.7 – 26.5 –
11α 29.6 2.15 m 27.2 1.91 m
β 1.40 m
12α 33.8 1.86 m 32.4 1.59 m
β 1.71 m 1.57 m
13 47.9 – 46.2 –
14 63.0 – 54.2 –
15α 31.5 2.18 m 28.1 1.91 m
β 1.28 m 1.44 m
16α 27.0 1.53 m 27.7 1.95 m
β 1.13 m 1.12 m
17 52.5 1.52 m 52.5 1.60 m
18 18.0 1.11 s 19.5 1.05 s
19A 29.8 0.87 d (4.0) 30.7 0.59 d (4.0) 
B 0.50 d (4.0) 0.38 d (4.0) 
20 35.8 1.48 m 36.4 1.44 m
21 18.6 0.92 (6.3) 18.6 0.90 d (6.3) 
22α 34.8 1.60 m 35.1
β 1.18 m 1.16 m
23α 31.2 2.10 m 31.4 2.11 m
β 1.85 m 1.88 m
24 152.0 – 152.2 –
25 42.7 2.36 sextet (6.5) 42.8 2.36 m
26A 66.1 3.56 dd (7.0, 10.4) 66.1 3.55 dd  
(7.0, 10.4)
B 3.51 dd (10.4, 7.0) 3.51 dd  
(10.4, 7.0)
27 16.6 1.04 d (7.0) 16.6 1.05 d (7.0) 
28 22.4 1.02 s 14.2 0.81 s
29 21.1 1.09 s 25.6 0.97 s
30 181.1 – 64.8 3.83 d (11.8) 
3.68 d (11.8) 
31 109.9 4.88 s 109.8 4.87 s
4.82 s 4.82 s
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Melanin determination in primary melanocytes 
treated with crude extracts and active compounds
Primary melanocytes were seeded in 24-well plates at a density of 
1 × 105 cells per well and following a 24-h incubation were treated with 
crude extract (1 and 10 mg/mL, compounds 1, 5, and the positive con-
trol, p-hydroquinone (10 and 100 µM each), DMSO, and K3PO4 buffer 
as negative controls and the media alone to serve as a blank.
Following 24-h and 48-h incubations, cells were rinsed with 
Dulbecco’s PBS (Sigma-Aldrich) and removed from the base of the 
well using a cell scraper. Cells were pelleted in an Eppendorf tube 
and solubilized in a solution of 1 N NaOH (Sigma-Aldrich) and 10 % 
DMSO ( > 99.7 %, Sigma-Aldrich) and incubated at 80 °C for 2 h. Fol-
lowing this, cells were centrifuged at 12 000 g for 10 min at room 
temperature, and the absorbance of 200 µL of the supernatants 
was determined at 470 nM using a Tecan Infinate Pro 200 plate 
reader. Melanin content of the supernatants was determined 
against a standard curve of synthetic melanin (synthetic, Sigma-
Aldrich) (0–20 ng/mL) and was expressed as ρg/cell.
Statistical analysis
Cell viability, tyrosinase activity, and melanin content data are pre-
sented as mean  ±  standard error of the mean (SEM) for 3 independ-
ent experiments (n = 3). Data were analyzed for significance (p  ≤ 
0.05) using one-way analysis of variance; post hoc Tukey test was 
then used to compare the means.
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